X

Download SPORE in Skin Cancer Research PowerPoint Presentation

SlidesFinder-Advertising-Design.jpg

Login   OR  Register
X


Iframe embed code :



Presentation url :

Home / Health & Wellness / Health & Wellness Presentations / SPORE in Skin Cancer Research PowerPoint Presentation

SPORE in Skin Cancer Research PowerPoint Presentation

Ppt Presentation Embed Code   Zoom Ppt Presentation

PowerPoint is the world's most popular presentation software which can let you create professional SPORE in Skin Cancer Research powerpoint presentation easily and in no time. This helps you give your presentation on SPORE in Skin Cancer Research in a conference, a school lecture, a business proposal, in a webinar and business and professional representations.

The uploader spent his/her valuable time to create this SPORE in Skin Cancer Research powerpoint presentation slides, to share his/her useful content with the world. This ppt presentation uploaded by slidesfinder in Health & Wellness ppt presentation category is available for free download,and can be used according to your industries like finance, marketing, education, health and many more.

About This Presentation

SPORE in Skin Cancer Research Presentation Transcript

Slide 1 - Yale SPORE in Skin Cancer Directors: Ruth Halaban, PhD Mario Sznol, MD Robert Tigelaar, MD Funded by: National Institutes of Health The Roslyn and Jeremy Meyer funds Yale Dermatology Department
Slide 2 - Yale SPORE in Skin Cancer Directors: Ruth Halaban, PhD Mario Sznol, MD Robert Tigelaar, MD Funded by: National Institutes of Health The Roslyn and Jeremy Meyer funds Yale Dermatology Department Milstein Meyer Center for Melanoma Research Jeremy Meyer and Roslyn Milstein Meyer “Couple with a Cause” Gift of $2 Million/year renewable for additional 4 years
Slide 3 - Yale SPORE in Skin Cancer Directors: Ruth Halaban, PhD Mario Sznol, MD Robert Tigelaar, MD Funded by: National Institutes of Health The Roslyn and Jeremy Meyer funds Yale Dermatology Department Milstein Meyer Center for Melanoma Research Jeremy Meyer and Roslyn Milstein Meyer “Couple with a Cause” Gift of $2 Million/year renewable for additional 4 years The SPORE Program Translation Research in Skin Cancer Melanomas Basal Cell Carcinoma
Slide 4 - Yale SPORE in Skin Cancer Directors: Ruth Halaban, PhD Mario Sznol, MD Robert Tigelaar, MD Funded by: National Institutes of Health The Roslyn and Jeremy Meyer funds Yale Dermatology Department Milstein Meyer Center for Melanoma Research Jeremy Meyer and Roslyn Milstein Meyer “Couple with a Cause” Gift of $2 Million/year renewable for additional 4 years The SPORE Program Translation Research in Skin Cancer Melanomas Basal Cell Carcinoma The SPORE Program Three cores that support SPORE activities Four translational projects Developmental Research Projects Career Development Projects
Slide 5 - Yale SPORE in Skin Cancer Directors: Ruth Halaban, PhD Mario Sznol, MD Robert Tigelaar, MD Funded by: National Institutes of Health The Roslyn and Jeremy Meyer funds Yale Dermatology Department Milstein Meyer Center for Melanoma Research Jeremy Meyer and Roslyn Milstein Meyer “Couple with a Cause” Gift of $2 Million/year renewable for additional 4 years The SPORE Program Translation Research in Skin Cancer Melanomas Basal Cell Carcinoma The SPORE Program Three cores that support SPORE activities Four translational projects Developmental Research Projects Career Development Projects Translational Research Team SPORE Expansion Number of Investigators 0 0 ( S u b m i s s i o n ) Y e a r 1 Y e a r 2 1 0 2 0 3 0 4 0 5 0 6 0 7 0 Roslyn Milstein Meyer Susan Cambria Robin Bessin Robert Heffernan
Slide 6 - Yale SPORE in Skin Cancer Directors: Ruth Halaban, PhD Mario Sznol, MD Robert Tigelaar, MD Funded by: National Institutes of Health The Roslyn and Jeremy Meyer funds Yale Dermatology Department Milstein Meyer Center for Melanoma Research Jeremy Meyer and Roslyn Milstein Meyer “Couple with a Cause” Gift of $2 Million/year renewable for additional 4 years The SPORE Program Translation Research in Skin Cancer Melanomas Basal Cell Carcinoma The SPORE Program Three cores that support SPORE activities Four translational projects Developmental Research Projects Career Development Projects Translational Research Team SPORE Expansion Number of Investigators 0 0 ( S u b m i s s i o n ) Y e a r 1 Y e a r 2 1 0 2 0 3 0 4 0 5 0 6 0 7 0 Roslyn Milstein Meyer Susan Cambria Robin Bessin Robert Heffernan Translational Research Team 1 Dermatology 2 YCCC/Oncology 3 Pathology 4 Surgery 5 Genetics 6 Immunobiology 7 Epidemiology 8 Chemical & Biomedical Engineering 9 Therapeutic Radiology 10 Laboratory Medicine and Genetics Molecular, Cellular, and Developmental Biology Cell Biology, New York University, NY
Slide 7 - Yale SPORE in Skin Cancer Directors: Ruth Halaban, PhD Mario Sznol, MD Robert Tigelaar, MD Funded by: National Institutes of Health The Roslyn and Jeremy Meyer funds Yale Dermatology Department Milstein Meyer Center for Melanoma Research Jeremy Meyer and Roslyn Milstein Meyer “Couple with a Cause” Gift of $2 Million/year renewable for additional 4 years The SPORE Program Translation Research in Skin Cancer Melanomas Basal Cell Carcinoma The SPORE Program Three cores that support SPORE activities Four translational projects Developmental Research Projects Career Development Projects Translational Research Team SPORE Expansion Number of Investigators 0 0 ( S u b m i s s i o n ) Y e a r 1 Y e a r 2 1 0 2 0 3 0 4 0 5 0 6 0 7 0 Roslyn Milstein Meyer Susan Cambria Robin Bessin Robert Heffernan Translational Research Team 1 Dermatology 2 YCCC/Oncology 3 Pathology 4 Surgery 5 Genetics 6 Immunobiology 7 Epidemiology 8 Chemical & Biomedical Engineering 9 Therapeutic Radiology 10 Laboratory Medicine and Genetics Molecular, Cellular, and Developmental Biology Cell Biology, New York University, NY “The Melanoma Landscape” Critical changes that drive melanomas Immunobiology of melanomas The causes for drug resistance New targets for therapy, single and combination Markers for prognosis and therapy Comprehensive understanding of:
Slide 8 - Yale SPORE in Skin Cancer Directors: Ruth Halaban, PhD Mario Sznol, MD Robert Tigelaar, MD Funded by: National Institutes of Health The Roslyn and Jeremy Meyer funds Yale Dermatology Department Milstein Meyer Center for Melanoma Research Jeremy Meyer and Roslyn Milstein Meyer “Couple with a Cause” Gift of $2 Million/year renewable for additional 4 years The SPORE Program Translation Research in Skin Cancer Melanomas Basal Cell Carcinoma The SPORE Program Three cores that support SPORE activities Four translational projects Developmental Research Projects Career Development Projects Translational Research Team SPORE Expansion Number of Investigators 0 0 ( S u b m i s s i o n ) Y e a r 1 Y e a r 2 1 0 2 0 3 0 4 0 5 0 6 0 7 0 Roslyn Milstein Meyer Susan Cambria Robin Bessin Robert Heffernan Translational Research Team 1 Dermatology 2 YCCC/Oncology 3 Pathology 4 Surgery 5 Genetics 6 Immunobiology 7 Epidemiology 8 Chemical & Biomedical Engineering 9 Therapeutic Radiology 10 Laboratory Medicine and Genetics Molecular, Cellular, and Developmental Biology Cell Biology, New York University, NY “The Melanoma Landscape” Critical changes that drive melanomas Immunobiology of melanomas The causes for drug resistance New targets for therapy, single and combination Markers for prognosis and therapy Comprehensive understanding of: SPORE Biospecimen Bank Normal skin and cells Tumors Tumor cells Blood from healthy individuals Blood from patients Specimen Tracking and Annotation caTissue
Slide 9 - Yale SPORE in Skin Cancer Directors: Ruth Halaban, PhD Mario Sznol, MD Robert Tigelaar, MD Funded by: National Institutes of Health The Roslyn and Jeremy Meyer funds Yale Dermatology Department Milstein Meyer Center for Melanoma Research Jeremy Meyer and Roslyn Milstein Meyer “Couple with a Cause” Gift of $2 Million/year renewable for additional 4 years The SPORE Program Translation Research in Skin Cancer Melanomas Basal Cell Carcinoma The SPORE Program Three cores that support SPORE activities Four translational projects Developmental Research Projects Career Development Projects Translational Research Team SPORE Expansion Number of Investigators 0 0 ( S u b m i s s i o n ) Y e a r 1 Y e a r 2 1 0 2 0 3 0 4 0 5 0 6 0 7 0 Roslyn Milstein Meyer Susan Cambria Robin Bessin Robert Heffernan Translational Research Team 1 Dermatology 2 YCCC/Oncology 3 Pathology 4 Surgery 5 Genetics 6 Immunobiology 7 Epidemiology 8 Chemical & Biomedical Engineering 9 Therapeutic Radiology 10 Laboratory Medicine and Genetics Molecular, Cellular, and Developmental Biology Cell Biology, New York University, NY “The Melanoma Landscape” Critical changes that drive melanomas Immunobiology of melanomas The causes for drug resistance New targets for therapy, single and combination Markers for prognosis and therapy Comprehensive understanding of: SPORE Biospecimen Bank Normal skin and cells Tumors Tumor cells Blood from healthy individuals Blood from patients Specimen Tracking and Annotation caTissue Specimens’ Collection in the Tissue Bank Total Number of Specimens 0 100 200 300 400 500 600 700 Submission Year 1 Year 2 Current Year 2 1/2
Slide 10 - Yale SPORE in Skin Cancer Directors: Ruth Halaban, PhD Mario Sznol, MD Robert Tigelaar, MD Funded by: National Institutes of Health The Roslyn and Jeremy Meyer funds Yale Dermatology Department Milstein Meyer Center for Melanoma Research Jeremy Meyer and Roslyn Milstein Meyer “Couple with a Cause” Gift of $2 Million/year renewable for additional 4 years The SPORE Program Translation Research in Skin Cancer Melanomas Basal Cell Carcinoma The SPORE Program Three cores that support SPORE activities Four translational projects Developmental Research Projects Career Development Projects Translational Research Team SPORE Expansion Number of Investigators 0 0 ( S u b m i s s i o n ) Y e a r 1 Y e a r 2 1 0 2 0 3 0 4 0 5 0 6 0 7 0 Roslyn Milstein Meyer Susan Cambria Robin Bessin Robert Heffernan Translational Research Team 1 Dermatology 2 YCCC/Oncology 3 Pathology 4 Surgery 5 Genetics 6 Immunobiology 7 Epidemiology 8 Chemical & Biomedical Engineering 9 Therapeutic Radiology 10 Laboratory Medicine and Genetics Molecular, Cellular, and Developmental Biology Cell Biology, New York University, NY “The Melanoma Landscape” Critical changes that drive melanomas Immunobiology of melanomas The causes for drug resistance New targets for therapy, single and combination Markers for prognosis and therapy Comprehensive understanding of: SPORE Biospecimen Bank Normal skin and cells Tumors Tumor cells Blood from healthy individuals Blood from patients Specimen Tracking and Annotation caTissue Specimens’ Collection in the Tissue Bank Total Number of Specimens 0 100 200 300 400 500 600 700 Submission Year 1 Year 2 Current Year 2 1/2 Serological Profiling of Melanoma Patients Weeks of Treatment Marker B Marker A Concentration (ng/ml)
Slide 11 - Yale SPORE in Skin Cancer Directors: Ruth Halaban, PhD Mario Sznol, MD Robert Tigelaar, MD Funded by: National Institutes of Health The Roslyn and Jeremy Meyer funds Yale Dermatology Department Milstein Meyer Center for Melanoma Research Jeremy Meyer and Roslyn Milstein Meyer “Couple with a Cause” Gift of $2 Million/year renewable for additional 4 years The SPORE Program Translation Research in Skin Cancer Melanomas Basal Cell Carcinoma The SPORE Program Three cores that support SPORE activities Four translational projects Developmental Research Projects Career Development Projects Translational Research Team SPORE Expansion Number of Investigators 0 0 ( S u b m i s s i o n ) Y e a r 1 Y e a r 2 1 0 2 0 3 0 4 0 5 0 6 0 7 0 Roslyn Milstein Meyer Susan Cambria Robin Bessin Robert Heffernan Translational Research Team 1 Dermatology 2 YCCC/Oncology 3 Pathology 4 Surgery 5 Genetics 6 Immunobiology 7 Epidemiology 8 Chemical & Biomedical Engineering 9 Therapeutic Radiology 10 Laboratory Medicine and Genetics Molecular, Cellular, and Developmental Biology Cell Biology, New York University, NY “The Melanoma Landscape” Critical changes that drive melanomas Immunobiology of melanomas The causes for drug resistance New targets for therapy, single and combination Markers for prognosis and therapy Comprehensive understanding of: SPORE Biospecimen Bank Normal skin and cells Tumors Tumor cells Blood from healthy individuals Blood from patients Specimen Tracking and Annotation caTissue Specimens’ Collection in the Tissue Bank Total Number of Specimens 0 100 200 300 400 500 600 700 Submission Year 1 Year 2 Current Year 2 1/2 Serological Profiling of Melanoma Patients Weeks of Treatment Marker B Marker A Concentration (ng/ml) Global “Omics” Test Genetic and epigenetic variations Mutations Gene expression Kinases and signal transducers MicroRNA
Slide 12 - Yale SPORE in Skin Cancer Directors: Ruth Halaban, PhD Mario Sznol, MD Robert Tigelaar, MD Funded by: National Institutes of Health The Roslyn and Jeremy Meyer funds Yale Dermatology Department Milstein Meyer Center for Melanoma Research Jeremy Meyer and Roslyn Milstein Meyer “Couple with a Cause” Gift of $2 Million/year renewable for additional 4 years The SPORE Program Translation Research in Skin Cancer Melanomas Basal Cell Carcinoma The SPORE Program Three cores that support SPORE activities Four translational projects Developmental Research Projects Career Development Projects Translational Research Team SPORE Expansion Number of Investigators 0 0 ( S u b m i s s i o n ) Y e a r 1 Y e a r 2 1 0 2 0 3 0 4 0 5 0 6 0 7 0 Roslyn Milstein Meyer Susan Cambria Robin Bessin Robert Heffernan Translational Research Team 1 Dermatology 2 YCCC/Oncology 3 Pathology 4 Surgery 5 Genetics 6 Immunobiology 7 Epidemiology 8 Chemical & Biomedical Engineering 9 Therapeutic Radiology 10 Laboratory Medicine and Genetics Molecular, Cellular, and Developmental Biology Cell Biology, New York University, NY “The Melanoma Landscape” Critical changes that drive melanomas Immunobiology of melanomas The causes for drug resistance New targets for therapy, single and combination Markers for prognosis and therapy Comprehensive understanding of: SPORE Biospecimen Bank Normal skin and cells Tumors Tumor cells Blood from healthy individuals Blood from patients Specimen Tracking and Annotation caTissue Specimens’ Collection in the Tissue Bank Total Number of Specimens 0 100 200 300 400 500 600 700 Submission Year 1 Year 2 Current Year 2 1/2 Serological Profiling of Melanoma Patients Weeks of Treatment Marker B Marker A Concentration (ng/ml) Global “Omics” Test Genetic and epigenetic variations Mutations Gene expression Kinases and signal transducers MicroRNA Global Epigenetic Differences Between Normal and Malignant Cells Melanoma Normal Gain Loss
Slide 13 - Yale SPORE in Skin Cancer Directors: Ruth Halaban, PhD Mario Sznol, MD Robert Tigelaar, MD Funded by: National Institutes of Health The Roslyn and Jeremy Meyer funds Yale Dermatology Department Milstein Meyer Center for Melanoma Research Jeremy Meyer and Roslyn Milstein Meyer “Couple with a Cause” Gift of $2 Million/year renewable for additional 4 years The SPORE Program Translation Research in Skin Cancer Melanomas Basal Cell Carcinoma The SPORE Program Three cores that support SPORE activities Four translational projects Developmental Research Projects Career Development Projects Translational Research Team SPORE Expansion Number of Investigators 0 0 ( S u b m i s s i o n ) Y e a r 1 Y e a r 2 1 0 2 0 3 0 4 0 5 0 6 0 7 0 Roslyn Milstein Meyer Susan Cambria Robin Bessin Robert Heffernan Translational Research Team 1 Dermatology 2 YCCC/Oncology 3 Pathology 4 Surgery 5 Genetics 6 Immunobiology 7 Epidemiology 8 Chemical & Biomedical Engineering 9 Therapeutic Radiology 10 Laboratory Medicine and Genetics Molecular, Cellular, and Developmental Biology Cell Biology, New York University, NY “The Melanoma Landscape” Critical changes that drive melanomas Immunobiology of melanomas The causes for drug resistance New targets for therapy, single and combination Markers for prognosis and therapy Comprehensive understanding of: SPORE Biospecimen Bank Normal skin and cells Tumors Tumor cells Blood from healthy individuals Blood from patients Specimen Tracking and Annotation caTissue Specimens’ Collection in the Tissue Bank Total Number of Specimens 0 100 200 300 400 500 600 700 Submission Year 1 Year 2 Current Year 2 1/2 Serological Profiling of Melanoma Patients Weeks of Treatment Marker B Marker A Concentration (ng/ml) Global “Omics” Test Genetic and epigenetic variations Mutations Gene expression Kinases and signal transducers MicroRNA Global Epigenetic Differences Between Normal and Malignant Cells Melanoma Normal Gain Loss Differences in Gene Expression Between Normal and Malignant Cells Melanoma Normal Loss Gain
Slide 14 - Yale SPORE in Skin Cancer Directors: Ruth Halaban, PhD Mario Sznol, MD Robert Tigelaar, MD Funded by: National Institutes of Health The Roslyn and Jeremy Meyer funds Yale Dermatology Department Milstein Meyer Center for Melanoma Research Jeremy Meyer and Roslyn Milstein Meyer “Couple with a Cause” Gift of $2 Million/year renewable for additional 4 years The SPORE Program Translation Research in Skin Cancer Melanomas Basal Cell Carcinoma The SPORE Program Three cores that support SPORE activities Four translational projects Developmental Research Projects Career Development Projects Translational Research Team SPORE Expansion Number of Investigators 0 0 ( S u b m i s s i o n ) Y e a r 1 Y e a r 2 1 0 2 0 3 0 4 0 5 0 6 0 7 0 Roslyn Milstein Meyer Susan Cambria Robin Bessin Robert Heffernan Translational Research Team 1 Dermatology 2 YCCC/Oncology 3 Pathology 4 Surgery 5 Genetics 6 Immunobiology 7 Epidemiology 8 Chemical & Biomedical Engineering 9 Therapeutic Radiology 10 Laboratory Medicine and Genetics Molecular, Cellular, and Developmental Biology Cell Biology, New York University, NY “The Melanoma Landscape” Critical changes that drive melanomas Immunobiology of melanomas The causes for drug resistance New targets for therapy, single and combination Markers for prognosis and therapy Comprehensive understanding of: SPORE Biospecimen Bank Normal skin and cells Tumors Tumor cells Blood from healthy individuals Blood from patients Specimen Tracking and Annotation caTissue Specimens’ Collection in the Tissue Bank Total Number of Specimens 0 100 200 300 400 500 600 700 Submission Year 1 Year 2 Current Year 2 1/2 Serological Profiling of Melanoma Patients Weeks of Treatment Marker B Marker A Concentration (ng/ml) Global “Omics” Test Genetic and epigenetic variations Mutations Gene expression Kinases and signal transducers MicroRNA Global Epigenetic Differences Between Normal and Malignant Cells Melanoma Normal Gain Loss Differences in Gene Expression Between Normal and Malignant Cells Melanoma Normal Loss Gain Interactions Between the SPORE and Clinicians Help in testing for mutations in tumors for targeted therapy For example: selection of patients to therapy with PLX4032 (Plexxikon Inc.) and Imatinib (Gleevec, Novartis Pharmaceuticals), activated BRAF and KIT inhibitors, respectively.
Slide 15 - Yale SPORE in Skin Cancer Directors: Ruth Halaban, PhD Mario Sznol, MD Robert Tigelaar, MD Funded by: National Institutes of Health The Roslyn and Jeremy Meyer funds Yale Dermatology Department Milstein Meyer Center for Melanoma Research Jeremy Meyer and Roslyn Milstein Meyer “Couple with a Cause” Gift of $2 Million/year renewable for additional 4 years The SPORE Program Translation Research in Skin Cancer Melanomas Basal Cell Carcinoma The SPORE Program Three cores that support SPORE activities Four translational projects Developmental Research Projects Career Development Projects Translational Research Team SPORE Expansion Number of Investigators 0 0 ( S u b m i s s i o n ) Y e a r 1 Y e a r 2 1 0 2 0 3 0 4 0 5 0 6 0 7 0 Roslyn Milstein Meyer Susan Cambria Robin Bessin Robert Heffernan Translational Research Team 1 Dermatology 2 YCCC/Oncology 3 Pathology 4 Surgery 5 Genetics 6 Immunobiology 7 Epidemiology 8 Chemical & Biomedical Engineering 9 Therapeutic Radiology 10 Laboratory Medicine and Genetics Molecular, Cellular, and Developmental Biology Cell Biology, New York University, NY “The Melanoma Landscape” Critical changes that drive melanomas Immunobiology of melanomas The causes for drug resistance New targets for therapy, single and combination Markers for prognosis and therapy Comprehensive understanding of: SPORE Biospecimen Bank Normal skin and cells Tumors Tumor cells Blood from healthy individuals Blood from patients Specimen Tracking and Annotation caTissue Specimens’ Collection in the Tissue Bank Total Number of Specimens 0 100 200 300 400 500 600 700 Submission Year 1 Year 2 Current Year 2 1/2 Serological Profiling of Melanoma Patients Weeks of Treatment Marker B Marker A Concentration (ng/ml) Global “Omics” Test Genetic and epigenetic variations Mutations Gene expression Kinases and signal transducers MicroRNA Global Epigenetic Differences Between Normal and Malignant Cells Melanoma Normal Gain Loss Differences in Gene Expression Between Normal and Malignant Cells Melanoma Normal Loss Gain Interactions Between the SPORE and Clinicians Help in testing for mutations in tumors for targeted therapy For example: selection of patients to therapy with PLX4032 (Plexxikon Inc.) and Imatinib (Gleevec, Novartis Pharmaceuticals), activated BRAF and KIT inhibitors, respectively. Educational Activities Invited speakers Research in Progress meetings Workshop for all SPOREs in Skin Cancer Outreach with patient advocates
Slide 16 - Yale SPORE in Skin Cancer Directors: Ruth Halaban, PhD Mario Sznol, MD Robert Tigelaar, MD Funded by: National Institutes of Health The Roslyn and Jeremy Meyer funds Yale Dermatology Department Milstein Meyer Center for Melanoma Research Jeremy Meyer and Roslyn Milstein Meyer “Couple with a Cause” Gift of $2 Million/year renewable for additional 4 years The SPORE Program Translation Research in Skin Cancer Melanomas Basal Cell Carcinoma The SPORE Program Three cores that support SPORE activities Four translational projects Developmental Research Projects Career Development Projects Translational Research Team SPORE Expansion Number of Investigators 0 0 ( S u b m i s s i o n ) Y e a r 1 Y e a r 2 1 0 2 0 3 0 4 0 5 0 6 0 7 0 Roslyn Milstein Meyer Susan Cambria Robin Bessin Robert Heffernan Translational Research Team 1 Dermatology 2 YCCC/Oncology 3 Pathology 4 Surgery 5 Genetics 6 Immunobiology 7 Epidemiology 8 Chemical & Biomedical Engineering 9 Therapeutic Radiology 10 Laboratory Medicine and Genetics Molecular, Cellular, and Developmental Biology Cell Biology, New York University, NY “The Melanoma Landscape” Critical changes that drive melanomas Immunobiology of melanomas The causes for drug resistance New targets for therapy, single and combination Markers for prognosis and therapy Comprehensive understanding of: SPORE Biospecimen Bank Normal skin and cells Tumors Tumor cells Blood from healthy individuals Blood from patients Specimen Tracking and Annotation caTissue Specimens’ Collection in the Tissue Bank Total Number of Specimens 0 100 200 300 400 500 600 700 Submission Year 1 Year 2 Current Year 2 1/2 Serological Profiling of Melanoma Patients Weeks of Treatment Marker B Marker A Concentration (ng/ml) Global “Omics” Test Genetic and epigenetic variations Mutations Gene expression Kinases and signal transducers MicroRNA Global Epigenetic Differences Between Normal and Malignant Cells Melanoma Normal Gain Loss Differences in Gene Expression Between Normal and Malignant Cells Melanoma Normal Loss Gain Interactions Between the SPORE and Clinicians Help in testing for mutations in tumors for targeted therapy For example: selection of patients to therapy with PLX4032 (Plexxikon Inc.) and Imatinib (Gleevec, Novartis Pharmaceuticals), activated BRAF and KIT inhibitors, respectively. Educational Activities Invited speakers Research in Progress meetings Workshop for all SPOREs in Skin Cancer Outreach with patient advocates Best-Case Scenario Mutations Activated targets Drug response Identify best therapy Tumor excised Draw blood Comprehensive analyses: Which therapy? Results Yes, this is the best for you
 

Frequently Asked Questions

> About SlidesFinder?

Slidesfinder is a website that allows users to upload and share their PowerPoint presentations online. It provides a platform for individuals and businesses to share their ideas and knowledge through presentations, and for others to view and download these presentations for educational or professional purposes.
Slidesfinder offers a wide range of presentation topics and categories, including business, education, science, technology, health, and more. Users can also search for presentations using keywords, tags, or by category. The website provides tools to create professional presentations with rich media, animations, and graphics.



One of the key features of Slidesfinder is its user-friendly interface, which allows users to easily upload, view, and share presentations. Users can also embed their presentations in their websites or blogs using the website's embed code feature.
Slidesfinder also offers premium services, such as the ability to create private presentations and to download presentations in high-quality formats. However, the basic features of Slidesfinder are free to use, making it accessible to anyone who wants to share their ideas and knowledge through presentations.

> How do I register with SlidesFinder?

Go to registration page (you can see signup link on top of website page) https://www.slidesfinder.com/signup . If you have facebook/gmail account them just click on SIGN IN WITH FACEBOOK OR SIGN IN WITH GOOGLE button, by this you will be a registered member of slidesfinder without filling any form, required detail automatically will be fatch from your account. If you do not a Facebook account, then click on "Signup". Fill all required fields and you will be a registered member of slidesfinder.

> Is slidesfinder account confirmation is mandatory?

Yes it is mandetory to active your account to login.

> Do I need to signup/login on SlidesFinder before uploading a PowerPoint presentation?

Yes, you need to login with your account before uploading presentation. Your username will be displayed on your uploaded presentation. Your registered email id is needed for sending your stats of uploaded presentation.

Slidesfinder is a sharing website for PowerPoint presentations search and share. Find your interest in the form of powerpoint presentations on slidesfinder and save your valuable time . On Slidesfinder you get presentations from our huge library of professional ppt presentations. We believe in making your search INFORMATIVE and FUN. Find your best ppt presentation from a pool of PowerPoint presentations stacked under important industry categories like business & management, heath & Wellness,eduction & training etc. We provide unique informative PowerPoint presentation for marketers, presenters and educationists. These professional PowerPoint presentations are uploaded by professionals from across numerous industry segments.These ppt presentations are available for FREE download.

Not just finding your interest, but facilitate you broadcast your interest. We have created this platform for easy sharing of PowerPoint presentations, ensuring that these presentations get maximum exposure. Create your slidesfinder account and upload PowerPoint presentations for free, share on social media platforms and BUILD YOUR CROWD WITH PRESENTATION !!

The Great Buddha says, "Share your knowledge.It’s a way to achieve immortality"! So, start sharing knowledge and we are here to make that immortal !!

© 2013-2024 SlidesFinder. All rights reserved.

Re-productivity of content are not allowed. Without prior written permission from author, commercial use of any content is illegal.